Abbott's (ABT) share recovery in the Nutrition business buoys optimism.
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often
Panagora Asset Management Inc. increased its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 2.8% during the 4th quarter, according to the company in its most recent disclosure with
I see a shift from growth to value stocks due to persistent inflation and interest rate challenges. Based on my thesis, I present four fantastic dividend growth stocks with great business models, attr
Abbott Laboratories is one of the smaller holdings in my portfolio, but that won't be the case for much longer. Strength throughout the base business powered the company's sales higher in the first qu
Fund managers have historically pivoted to top dividend stocks in low-interest-rate environments. With the Fed poised to start cutting interest rates within the next eight to 12 months, these two blue
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
If you want your portfolio to pay you cash like clockwork, it's time to stop blindly following conventional wisdom like relying on Dividend Aristocrats.
Indian drugmaker Abbott India reported a 24% rise in fourth-quarter profit on Thursday, as strong sales outpaced the impact of government pricing caps on certain medicines.
Often overlooked, especially in times of AI revolution, the healthcare market is always a safe bet for investors, as it is a multiple trillion, highly innovative industry with no drawbacks like lack o
Johnson & Johnson is a steady portfolio stalwart. Abbott Labs has exciting growth opportunities ahead.
IRVINE, Calif.--(BUSINESS WIRE)--Appriss Retail, a leading provider of data and analytics solutions designed to reduce retail losses, decrease returns, and provide a more seamless consumer experience,
Healthcare stocks certainly haven't set the world on fire lately. The S&P Health Care Index is up 3% so far in 2024 compared to an 8% gain in the benchmark S&P 500.
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
Investors looking for stocks in the Medical - Products sector might want to consider either Prestige Consumer Healthcare (PBH) or Abbott (ABT). But which of these two companies is the best option for
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE